Literature DB >> 27673578

A Synthesis of Exiguaquinol Dessulfate.

Gregg M Schwarzwalder1, David R Scott2, Christopher D Vanderwal1.   

Abstract

A concise and stereoselective synthesis of exiguaquinol dessulfate is described. Sequential application of a Diels-Alder cycloaddition, a desymmetrizing aldol addition, and a reductive Heck cyclization established most of the architecture of exiguaquinol, and a carefully choreographed introduction of the polar substituents afforded the title compound; unfortunately, naphthoquinol sulfation could not be achieved to deliver exiguaquinol. Our hypothesis regarding the configurational preference of the N-acyl hemiaminal, which was based upon an analysis of internal hydrogen-bonding interactions with polar functional groups, was proven correct. A late-stage intermediate did not demonstrate bactericidal activity against H. pylori cultures.
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Heck cyclization; antibiotics; epimers; natural product synthesis; sulfation

Mesh:

Substances:

Year:  2016        PMID: 27673578      PMCID: PMC6028001          DOI: 10.1002/chem.201604506

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  22 in total

1.  Synthesis of Functionalized Naphthalenes from Substituted 1-Methoxybenzocyclobutenes.

Authors:  Neil G. Andersen; Shawn P. Maddaford; Brian A. Keay
Journal:  J Org Chem       Date:  1996-04-19       Impact factor: 4.354

2.  Asymmetric total synthesis of the proposed structure of the medicinal alkaloid jamtine using the chiral base approach.

Authors:  Nigel S Simpkins; Christopher D Gill
Journal:  Org Lett       Date:  2003-02-20       Impact factor: 6.005

3.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

4.  Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy.

Authors:  Boudewijn L M de Jonge; Amy Kutschke; Joseph V Newman; Michael T Rooney; Wei Yang; Christer Cederberg
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

5.  Design, development, mechanistic elucidation, and rational optimization of a tandem Ireland Claisen/Cope rearrangement reaction for rapid access to the (iso)cyclocitrinol core.

Authors:  Christopher W Plummer; Carolyn S Wei; Carrie E Yozwiak; Arash Soheili; Sara O Smithback; James L Leighton
Journal:  J Am Chem Soc       Date:  2014-06-30       Impact factor: 15.419

6.  Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty.

Authors:  Gregory S Basarab; Pamela Hill; Charles J Eyermann; Madhu Gowravaram; Helena Käck; Ekundayo Osimoni
Journal:  Bioorg Med Chem Lett       Date:  2012-07-20       Impact factor: 2.823

7.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

8.  Exiguaquinol: a novel pentacyclic hydroquinone from Neopetrosia exigua that inhibits Helicobacter pylori MurI.

Authors:  Priscila de Almeida Leone; Anthony R Carroll; Leanne Towerzey; Gordon King; Bernadette M McArdle; Gunther Kern; Stewart Fisher; John N A Hooper; Ronald J Quinn
Journal:  Org Lett       Date:  2008-05-20       Impact factor: 6.005

9.  Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).

Authors:  B L M de Jonge; A Kutschke; M Uria-Nickelsen; H D Kamp; S D Mills
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

10.  Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core.

Authors:  Matthew B Kraft; Yam B Poudel; Noemi Kedei; Nancy E Lewin; Megan L Peach; Peter M Blumberg; Gary E Keck
Journal:  J Am Chem Soc       Date:  2014-09-10       Impact factor: 15.419

View more
  1 in total

1.  Strategies for the Synthesis of the Halenaquinol and Xestoquinol Families of Natural Products.

Authors:  Gregg M Schwarzwalder; Christopher D Vanderwal
Journal:  European J Org Chem       Date:  2017-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.